InfectivologyNews.net

Infectivology Xagena

Search results for "Sustiva"

Schering-Plough has discontinued a Phase II study with its investigational CCR5 receptor antagonist, Vicriviroc, used in combination with Combivir in treatment-naive HIV patients. This decision was ...


The way the body metabolizes an anti-retroviral drug that is used long term by patients infected with virus HIV may contribute to cognitive impairment by damaging nerve cells.Nearly 50 percent of peop ...